Developing new drug therapies and providing them to patients is a complex process. At Certara, we have brought together a unique set of disciplines and technologies to address those underlying factors. We are the industry leader in applying a quantitative decision-making framework across the drug development life cycle, bridging from safety and efficacy to effectiveness.
Our work covers virtually all therapeutic areas, including oncology, immunology, rare disease, CNS, metabolic and infectious disease and complex biologics. We support the development and patient access challenges associated with special populations, such as pediatrics, geriatrics, co-morbidity and global health. We have unmatched expertise working under unique regulatory programs, such as breakthrough, orphan and priority review, in concert with all major regulatory and global health authorities.